Cargando…
Specific Inhibitor of Matrix Metalloproteinase Decreases Tumor Invasiveness After Radiofrequency Ablation in Liver Tumor Animal Model
OBJECTIVE: To determine whether the specific inhibitor of matrix metalloproteinase (MMP)—batimastat (BB-94)—could decrease the progression of liver tumor after radiofrequency ablation (RFA) and achieve better therapeutic efficacy in an animal model. METHODS: In vitro experiments, the proliferation o...
Autores principales: | Jiang, An-Na, Liu, Jing-Tao, Zhao, Kun, Wu, Hao, Wang, Song, Yan, Kun, Yang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709861/ https://www.ncbi.nlm.nih.gov/pubmed/33330030 http://dx.doi.org/10.3389/fonc.2020.561805 |
Ejemplares similares
-
Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019) -
The study of direct and indirect effects of radiofrequency ablation on tumor microenvironment in liver tumor animal model
por: Jiang, An-Na, et al.
Publicado: (2022) -
Early Assessment of Response to Radiofrequency Ablation With CT Perfusion Imaging in Rabbit VX2 Liver Tumor Model
por: Yue, Xiaofei, et al.
Publicado: (2021) -
Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer
por: Zhang, Zhong-Yi, et al.
Publicado: (2022) -
Palliative Radiofrequency Ablation Accelerates the Residual Tumor Progression Through Increasing Tumor-Infiltrating MDSCs and Reducing T-Cell-Mediated Anti-Tumor Immune Responses in Animal Model
por: Wu, Hao, et al.
Publicado: (2020)